Center for Interventions, Treatment, and Addictions Research (CITAR)

Research News

Evaluating the Diversion of Buprenorphine Products

Research suggests that increases in the non-medical use of diverted buprenorphine products are driven by people self-treating opioid withdrawal. The overall purpose of this four-year, natural history study, funded by NIDA, is to describe and analyze the illicit use of buprenorphine in the self-treatment of symptoms of opioid use disorder.  https://medicine.wright.edu/citar/a-natural-history-study-of-diverted-buprenorphine-use

Social media analysis used to monitor cannabis and synthetic cannabinoid use

Another newly funded project uses social media to address substance use and addiction. eDrugTrends is an interdisciplinary collaboration to develop software to identify trends and analyze social networks to monitor cannabis and synthetic cannabinoid use. The NIH/NIDA-funded project builds on previoius work CITAR and Kno.e.sis did to analyze web forum data on illicit buprenorphine use.

Welcome

The Center for Interventions, Treatment and Addictions Research (CITAR) is administratively housed within Boonshoft School of Medicine's Department of Population and Public Health Sciences. It represents the focal point for substance abuse related services, academic research, and services research. Although the larger purpose of the Center is to advance the production, dissemination and utilization of scientific knowledge and professional technology regarding the epidemiology, consequences, prevention and treatment of substance abuse, its goals are directed at the understanding of substance abuse phenomena and their intervention and management in smaller and mid-sized cities and their surrounding suburban and rural communities.

CITAR was founded by a member of the Wright State University School of Medicine faculty, the late Harvey A. Siegal, Ph.D., in 1980. Dr. Siegal continued as director until his death in December 2004. Robert G. Carlson, Ph.D., professor of community health and a member of the CITAR staff since 1989, was appointed director in May 2005.

The following projects and programs currently operate within CITAR:

In addition, the center provides consultation and program evaluation services.


Vital Signs articles featuring CITAR

These are articles about CITAR projects from Vital Signs, the School of Medicine magazine, and news releases.

Free reprints of articles authored by CITAR staff are available by contacting the respective projects.


Links to Related Websites


CITAR in the News

Wright State research team finds increase in deaths from fentanyl and fentanyl analogs

Evidence from the study indicates the increasing and substantial role of illicitly manufactured fentanyl and the declining presence of heroin and pharmaceutical opioids in overdose fatalities.

Wright State researcher mentioned in The Atlantic

The Atlantic cited the loperamide research of Raminta Daniulaityte, Ph.D., associate professor in the Department of Population and Public Health Sciences.

Researchers study nonpharmaceutical fentanyl abuse

Boonshoft School of Medicine researchers receive $407,814 two-year grant from the National Institutes of Health/National Institute on Drug Abuse.
Last edited on 02/18/2019.